Serial Number | 98203880 |
Word Mark | INGREZZA |
Filing Date | Friday, September 29, 2023 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, June 18, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, June 18, 2024 |
Goods and Services | Administration of a program for enabling patients to obtain discounts on prescription drug spending |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, October 12, 2023 |
Primary Code | 035 |
First Use Anywhere Date | Wednesday, November 8, 2017 |
First Use In Commerce Date | Wednesday, November 8, 2017 |
Party Name | Neurocrine Biosciences, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 92130 |
Party Name | Neurocrine Biosciences, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 92130 |
Event Date | Event Description |
Tuesday, October 3, 2023 | NEW APPLICATION ENTERED |
Wednesday, May 15, 2024 | ASSIGNED TO EXAMINER |
Wednesday, May 15, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, May 29, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, June 18, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, June 18, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Thursday, October 12, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |